Shashank K R on The Use of Lumbrokinase from Eudrilus eugeniae
Shashank K R, Assistant Lecturer at Yuvaraja’s College, shared on LinkedIn:
”Cardiovascular diseases driven by thrombosis remain a major global health challenge.
Our study focuses on the isolation, purification, and biochemical characterization of lumbrikinase from Eudrilus eugeniae, demonstrating strong fibrinolytic activity, favorable kinetics, and stability under physiological conditions—highlighting its potential as a safer and effective thrombolytic agent for cardiovascular therapeutics.”
Read the full article here.
Article: Exploring the Fibrinolytic and Biochemical characteristics of Lumbrokinase enzyme from Eudrilus eugeniae for Therapeutic Use
Authors: Shashank K R, Malliah Mahadevaswamy
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 2, 2026, 18:16Saravanan Subramaniam: How Extracellular Histones Act as Key Drivers of Thromboinflammation
-
Apr 2, 2026, 18:06Rob Molhoek Brings Invaluable Insights on Stroke Awareness and Care Improvements – Stroke Foundation
-
Apr 2, 2026, 17:21Paul Bolaji: Phase 2 of the Nigeria National Stroke Registry Is Now Live
-
Apr 2, 2026, 17:13Catherine Jennings: Marking Today as an Important Step Forward for Patients With PE
-
Apr 2, 2026, 17:11Arun V. J: Our Clinical Audit on Transfusion Safety Selected for Presentation at CAHOCON 2026
-
Apr 2, 2026, 17:10Maxime Dely: Better Collection, Better Blood – The Quality Starts Now
-
Apr 2, 2026, 17:09Arun Danewa: Saving a Bone Marrow Patient from Hidden Enemy – TA-TMA
-
Apr 2, 2026, 17:07Cathy Harrison: The WFH Nurses Committee are Looking for New Members
-
Apr 2, 2026, 16:30Sam K. Saha: The Hardest Cases Are the Ones You Can’t Save